Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib

Determination of the presence of epidermal growth factor receptor (EGFR) gene mutation is useful for predicting the efficacy of gefitinib. However, the survival rate following the initiation of treatment with gefitinib varies among individuals. A retrospective study was conducted to investigate the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mol Clin Oncol
Hauptverfasser: INOMATA, MINEHIKO, HAYASHI, RYUJI, YAMAMOTO, AZUSA, TOKUI, KOTARO, TAKA, CHIHIRO, OKAZAWA, SEISUKE, KAMBARA, KENTA, SUZUKI, KENSUKE, ICHIKAWA, TOMOMI, YAMADA, TORU, MIWA, TOSHIRO, KASHII, TATSUHIKO, MATSUI, SHOKO, TOBE, KAZUYUKI, IMURA, JOHJI
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2015
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486842/
https://ncbi.nlm.nih.gov/pubmed/26171184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.568
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge